📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A lentiviral vector manufactured under GMP for a Phase I study in Acute Myeloid Leukaemia - manufacture summary, safety testing, application and post-administration safety-monitoring (2012)

First Author: Chan Lucas

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 23

Parent Publication: HUMAN GENE THERAPY

Issue: 5

ISSN: 1043-0342